glp-1 drugs long term effects The Long-Term Side of Drugs: What We Know So Far Govt warns on rapid uptake

Without PBS subsidy for obesity indications, patients pay full price: Wegovy: approximately $320$450 per month Saxenda: approximately $390$440 per month Mounjaro (off-label for weight loss): approximately $280$750 per month depending on dose PBS listing for obesity indications is an ongoing discussion, with health economists and advocacy groups pushing for subsidised access given the long-term healthcare costs associated with untreated obesity

Collagen Supplements for Aging and Wrinkles: A Paradigm Shift in the Fields of Dermatology and Cosmetics

In the meantime: Dont rush to gray-market sources

Cardiovascular benefit for GLP-1RAs was shown in 2016 for liraglutide in the LEADER trial and semaglutide in the SUSTAIN 6 trial